Investing in cutting-edge drug companies can reward you with both money and satisfaction; you could be funding a cure. But the risks are high. Elan offers a good case study.




This article is courtesy of MSN Money Investing Ideas
Big caps are all the rage | Why I Like Penny Stocks | Time to re-balance your portfolio?

Add to Google
Technorati tags: footsie • footsie news • ftse • london stock exchange • new york stock exchange • stock exchange
Flickr tags: footsie • footsie news • ftse • london stock exchange • new york stock exchange • stock exchange
Tags: footsie, footsie news, ftse, london stock exchange, new york stock exchange, stock exchange
Categories: Daily Reports
Add To My Favourites